KELLY MCINTYRE: Open Payments
NPI 1902447568 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 14 payments from 9 companies in 2025. Trend: 2023 $613 · 2024 $615 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $156 |
| Noven Therapeutics, LLC | 1 | $120 |
| Alkermes, Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 2 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
| Lundbeck LLC | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| CORDIS US CORP. | 2 | $34 |
| ABBVIE INC. | 2 | $31 |
Products named: CAPLYTA, Xelstrym, LYBALVI, Auvelity, UZEDY, REXULTI, INVEGA SUSTENNA, MYNX CONTROL VENOUS.
Industry payments across KY — which companies pay providers there.
